SynthesisObesity surgery2026
The Impact of Metabolic Bariatric Surgery on the Incidence of Breast Cancer in Patients with Obesity: A Systematic Review and Meta-Analysis.
Synthesis in Obesity surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionObesity is widely recognized as an important risk factor for breast cancer, largely due to its effects on hormonal regulation, chronic low-grade inflammation, and metabolic dysfunction. Metabolic bariatric surgery (MBS) produces long-term weight reduction and improves metabolic profiles, which may influence the development of obesity-related cancers. This systematic review and meta-analysis aimed to examine the relationship between bariatric surgery and breast cancer incidence in adult women with obesity.
methodsThis review followed the PRISMA reporting standards and was registered in PROSPERO. A comprehensive search of PubMed, Google Scholar, Cochrane Library, and Web of Science was performed to identify studies comparing adult underwent metabolic bariatric surgery (MBS) with those managed without surgery. Breast cancer incidence was defined as the primary outcome. Study screening, data extraction, and quality appraisal were carried out independently by multiple reviewers. Pooled hazard ratios (HRs) and 95% confidence intervals (CIs) were calculated using a random-effects model.
resultsEight eligible studies involving 793,197 participants were included in the analysis. Among them, 140,880 women had undergone bariatric surgery, while 652,317 received non-surgical management. Women who underwent metabolic bariatric surgery demonstrated a significantly lower incidence of breast cancer compared with non-surgical controls (pooled HR 0.61; 95% CI 0.46-0.80). This risk reduction was observed in both premenopausal and postmenopausal populations.
conclusionAmong women with obesity, metabolic bariatric surgery is associated with a substantially reduced risk of developing breast cancer. While these findings suggest a potential protective effect, further large- scale prospective studies are necessary to clarify causality and identify patients who may benefit most from surgical intervention.
Indexed as
Identifiers
42298137What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.